Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Online Discussions

Updated 16 December 2009 E-mail discussion
Printable version

Live Discussion: DISC1 Roundtable 2010


David Porteous

Akira Sawa

It has been a busy year again for the DISC1 research community, so we invite you to join us once again for a live discussion on Wednesday, 13 January 2010, from 12:00 noon to 1 p.m. (U.S. EST), led by Akira Sawa, Johns Hopkins University, and David Porteous, University of Edinburgh. DISC1 barely needs introduction or justification any longer as a suitable topic for SRF discussion.

DISC1 is now well established as what Tom Insel, Director of the U.S. National Institute of Mental Health, has termed an “edge piece” of psychiatric genetics. Many studies have reported effects of DISC1 genetic variation on a spectrum of psychiatric disorders, including and extending beyond the schizophrenia, bipolar disorder, unipolar depression, and adolescent conduct disorder reported in the original Scottish family with a balanced t(1;11) translocation through which DISC1 was identified. The neurodevelopmental and neurosignaling roles of DISC1 are increasingly well understood through the scaffold function of DISC1, including GSK3β, PCM1, PDE4, NDE1, and NDEL1, to name but some of the currently most interesting and well studied interactors that are illuminating normal and pathogenetic brain processes. (See Brandon et al., 2009; Porteous and Millar, 2009; Jaaro-Peled et al., 2009; and Chubb et al., 2008 for more background and review summaries.)

The focus of this meeting will be as follows:

1. Update on animal models: What are these models telling us about the neurobiology of DISC1? What are the key DISC1-associated behavioral phenotypes? What kinds of criteria, including histological and molecular hallmarks, are most relevant to translational research? What experiments still need to be done? What other models are needed?

2. Update on DISC1 genetics: What is the status on evidence for common risk variants and rare mutations in the DISC1 pathway? What do these tell us about genotype-phenotype relationships? What do they tell us about structure-function relationships?

3. Update on DISC1 signalosome: What underlies the temporal and spatial specificity of DISC1 pathways in brain circuitry, such as isoform disposition, post-translational modifications, and different combinations of protein interactors?

We now invite your comments in advance of the live discussion and look forward to your participation.

See also DISC1 Roundtable 2009 and The DISC1 Pathway in Major Mental Illness: Clinical, Genetic and Biological Evidence—Current Status and Future Prospects.

View Transcript of Live Discussion — Posted 4 June 2010

View Comments By:
Mikhail Pletnikov — Posted 12 January 2010
Atsushi Kamiya — Posted 12 January 2010
Bernard Crespi — Posted 12 January 2010
Tatiana Lipina — Posted 12 January 2010
David St Clair — Posted 12 January 2010
Chris Carter — Posted 22 June 2010



Comments on Online Discussion
Comment by:  Mikhail Pletnikov
Submitted 12 January 2010 Posted 12 January 2010

To follow up on Atsushi's and Tatiana's comments, I would like to suggest we need to start thinking and going beyond the existing cell and mouse DISC1 models that have been focused on neuronal functions of DISC1. It may be a good time to begin developing approaches to address possible glial functions of DISC1 as well. The first available data are promising, but, of course, require further replications and confirmations.

View all comments by Mikhail Pletnikov


Comment by:  Atsushi Kamiya
Submitted 11 January 2010 Posted 12 January 2010

Accumulating evidence suggests that DISC1 plays roles in various aspects of cell behavior, including a role in cell proliferation, neuronal migration, axon growth, and dendritic/spine development during brain development and even in adulthood (Duan et al., 2007; Enomoto et al., 2009; Kamiya et al., 2005; Mao et al., 2009; Meyer and Morris, 2009). These results clearly indicate the importance of the timing of gene targeting for the study of such multifunctional molecules. DISC1 is a protein that interacts with many other molecules. Interestingly, some interactors, such as NDEL1, NDE1, PDE4, and PCM1, were also reported as risk factors for schizophrenia (Burdick et al., 2008; Gurling et al., 2006; Hennah et al.,...  Read more


View all comments by Atsushi Kamiya

Comment by:  Bernard Crespi
Submitted 12 January 2010 Posted 12 January 2010

A recent study (Crepel et al., 2010) has reported autism in a family with duplication of the DISC1 region. May I ask, has there been any work, or is work planned, on animal models that would allow functional analyses of the effects of increased expression of DISC1?

References:

Crepel A, Breckpot J, Fryns JP, De la Marche W, Steyaert J, Devriendt K, Peeters H. DISC1 duplication in two brothers with autism and mild mental retardation. Clin Genet . 2009 Dec 10. Abstract

View all comments by Bernard Crespi


Comment by:  Tatiana Lipina
Submitted 12 January 2010 Posted 12 January 2010

Response to: 1. Update on animal models: What are these models telling us about the neurobiology of DISC1? What are the key DISC1-associated behavioral phenotypes? What kinds of criteria, including histological and molecular hallmarks, are most relevant to translational research? What experiments still need to be done? What other models are needed?

Accumulating data based on neurobehavioral phenotypes of different Disc1-modified mouse models indicate major commonalities such as changes in the brain volume and ventricle size; altered density of spines on neurons; hyperactivity; deficient sensorimotor gating; social behavior; immobility in the forced swim test. Pharmacologically, still not many models have been used to probe the efficacy of different antipsychotics or response to psychostimulants. A summary of phenotypes of different Disc1 mouse models could be find in the paper of Shen et al., 2008.

The most recent progress in the Disc1 field is related to the neurodevelopmental part of schizophrenia, and the excellent...  Read more


View all comments by Tatiana Lipina

Comment by:  David St Clair
Submitted 12 January 2010 Posted 12 January 2010

I am currently at NIMH as visiting scientist. Barbara Lipska and I are planning to examine blood RNA transcripts from two schizophrenia cases with probable stop codons in DISC1. If anyone has other DISC1 mutations please let us know as we can analyze at the same time.

View all comments by David St Clair


Comment by:  Chris Carter
Submitted 20 June 2010 Posted 22 June 2010

DISC1 is clearly hugely important, acting as a "hub gene" linked to other susceptibility gene products in both bipolar disorder and schizophrenia. A DISC1 interactome was posted on the Polygenic Pathways website in 2007 and has now been updated (based on the work of many in this online discussion). It shows a plethora of susceptibility gene products linked to DISC1 in either one or two steps. This is most evident in schizophrenia, but is also impressive in bipolar disorder.

This updated interactome, specifically in relation to other bipolar and schizophrenia gene candidates, is posted at Polygenic Pathways, where links to the BIOGRID, PSTIING, and HPRD interactomes are also provided.

The interactions are referenced and also derive from the interactions section of Entrez Gene. For some...  Read more


View all comments by Chris Carter
Submit a Comment on This Online Discussion
Make a comment on this live discussion. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:



SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark
Live Discussion FAQs

Webinar: A Webinar is a seminar conducted remotely over the Web. Attendees view the slides through their Web browser and hear the presentations over their own telephones.

Registration: All participants are to register by clicking on the "Register for the Webinar" link.

Access: After you register, you will receive an e-mail with a link to the Webinar and a phone number.
New Schizophrenia Fact Sheet for Patients and Families

Latest BBRF Research Breakthroughs

Visit our Facebook page and our Blog.

Support the Brain & Behavior Research Foundation Today.

Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright